Net Worth Advisory Group’s West Pharmaceutical WST Stock Holding History

Net Worth Advisory Group’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$694K	Sell	1,933 -198	-9%	-$60.5K	0.17%	137
2026 Q1	$534K	Buy	2,131 +356	+20%	+$88.6K	0.11%	190
2025 Q4	$488K	Sell	1,775 -312	-15%	-$85.3K	0.1%	216
2025 Q3	$547K	Sell	2,087 -1,687	-45%	-$410K	0.16%	150
2025 Q2	$826K	Buy	3,774 +922	+32%	+$197K	0.18%	106
2025 Q1	$639K	Buy	2,852 +1,004	+54%	+$277K	0.2%	109
2024 Q4	$605K	Sell	1,848 -227	-11%	-$71.4K	0.18%	134
2024 Q3	$623K	Buy	+2,075	New	+$635K	0.18%	149

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Net Worth Advisory Group's WST Position: Q2 2026 in Review

Net Worth Advisory Group reduced its West Pharmaceutical (WST) stake by 9.3% in Q2 2026, selling an estimated $60.5K and leaving 1,933 shares worth $694K. The position accounts for 0.17% of the portfolio, ranked #137.

Net Worth Advisory Group first reported a position in WST in Q3 2024 and has held it in 8 quarters since. The position peaked at $826K in Q2 2025. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Net Worth Advisory Group held 1,933 shares of West Pharmaceutical worth $694K as of Q2 2026.
Net Worth Advisory Group sold 198 West Pharmaceutical shares in Q2 2026, an estimated $60.5K.
West Pharmaceutical made up 0.17% of Net Worth Advisory Group's portfolio in Q2 2026, its #137 holding.
Net Worth Advisory Group first reported a position in West Pharmaceutical in Q3 2024 and has held it in 8 quarters since.
Net Worth Advisory Group's West Pharmaceutical position peaked at $826K in Q2 2025.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Net Worth Advisory Group's 13F filing for Q2 2026, filed 14 Jul 2026.